Materialise NV

Chart & Performance

D1W1MN

P/E

21.99

P/S

1.11

EPS

0.23

Div Yield, %

—

Shrs. gr., 5y

1.83%

Rev. gr., 5y

6.29%

Revenues

267m

+4.15%

Net income

13m

+99.88%

CFO

31m

+56.05%

Profile

Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

URL

https://www.materialise.com/en

IPO date

Jun 25, 2014

Employees

2,439

Domiciled in

Incorporated in

Valuation

Order:

Title EUR in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title EUR in thousands, except ratios and share amounts	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues	266,765 4.15%	256,127 10.39%	232,023 12.93%
Cost of revenue	261,557	243,984	238,091
Unusual Expense (Income)
NOPBT	5,208	12,143	(6,068)
NOPBT Margin	1.95%	4.74%
Operating Taxes	733	78	975
Tax Rate	14.07%	0.64%
NOPAT	4,475	12,065	(7,043)
Net income	13,436 99.88%	6,722 -412.22%	(2,153) -116.37%
Dividends
Dividend yield
Proceeds from repurchase of equity			23
BB yield			0.00%
Debt
Debt current	12,997	25,483	19,960
Long-term debt	36,013	46,858	69,069
Deferred revenue			9,277
Other long-term liabilities	17,379	16,172	1,610
Net debt	(57,288)	(58,976)	(55,639)
Cash flow
Cash from operating activities	31,456	20,157	24,709
CAPEX	(24,649)	(9,235)	(24,773)
Cash from investing activities	(28,588)	(11,037)	(53,923)
Cash from financing activities	(27,644)	(22,368)	(24,869)
FCF	(9,699)	9,885	(16,234)
Balance
Cash	102,304	127,573	140,867
Long term investments	3,994	3,744	3,801
Excess cash	92,960	118,511	133,067
Stockholders' equity	14,264	2,651	(13,235)
Invested Capital	292,891	314,512	332,784
ROIC	1.47%	3.73%
ROCE	1.70%	3.83%
EV
Common stock shares outstanding	59,105	59,085	59,064
Price	7.04 7.24%	6.57 -25.40%	8.80 -63.13%
Market cap	416,099 7.27%	387,893 -25.37%	519,763 -61.69%
EV	358,725	328,864	464,097
EBITDA	27,015	33,712	16,500
EV/EBITDA	13.28	9.76	28.13
Interest		2,089	4,420
Interest/NOPBT		17.20%